Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment - Cell Type-Specific Findings (Part 2).

Lin, Y-J; Goretzki, A; Rainer, H; Zimmermann, J; Schülke, Stefan

Lin, Y-J; Goretzki, A; Rainer, H; Zimmermann, J; Schülke, Stefan.

Afiliación

Lin YJ; Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.
Goretzki A; Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.
Rainer H; Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.
Zimmermann J; Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany.
Schülke S; Vice President's Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany. Stefan.Schuelke@pei.de.

Curr Allergy Asthma Rep ; 23(1): 41-52, 2023 01.

Article en En | MEDLINE | ID: mdl-36520269

Asunto(s)

Hipersensibilidad; Inmunidad Innata; Humanos; Linfocitos; Hipersensibilidad/terapia; Células Th2/metabolismo; Mastocitos; Citocinas/metabolismo

Palabras clave

APC; Allergy; Fatty acid oxidation; ILC2; Immune metabolism; Immunotherapy; Oxidative phosphorylation; Th2; Warburg

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipersensibilidad / Inmunidad Innata Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Curr Allergy Asthma Rep Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google